The dexamethasone-induced inhibitor of fibrinolytic activity in hepatoma cells. A cellular product which specifically inhibits plasminogen activation

Dexamethasone induces an inhibitor of plasminogen-dependent fibrinolysis in rat hepatoma (HTC) cells. The specificity of the inhibitor for urokinase and plasmin was investigated using both fibrinolytic and esterolytic assays. Urokinase, but not plasmin, was inhibited by serum-free conditioned medium...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 1982-04, Vol.257 (8), p.4260-4264
Main Authors: Coleman, P L, Barouski, P A, Gelehrter, T D
Format: Article
Language:English
Subjects:
Animals
Cell Line
Culture Media
Dexamethasone - pharmacology
Fibrinolysin - antagonists & inhibitors
Fibrinolysis - drug effects
Kinetics
Liver Neoplasms, Experimental - physiopathology
Plasminogen - metabolism
Rats
Urokinase-Type Plasminogen Activator - antagonists & inhibitors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c434t-4bd263e1e6bc6d4e0465c1b838c4e0fc202d3fcc5d5ca124e003fb9747ecc2513
cites cdi_FETCH-LOGICAL-c434t-4bd263e1e6bc6d4e0465c1b838c4e0fc202d3fcc5d5ca124e003fb9747ecc2513
container_end_page 4264
container_issue 8
container_start_page 4260
container_title The Journal of biological chemistry
container_volume 257
creator Coleman, P L
Barouski, P A
Gelehrter, T D
description Dexamethasone induces an inhibitor of plasminogen-dependent fibrinolysis in rat hepatoma (HTC) cells. The specificity of the inhibitor for urokinase and plasmin was investigated using both fibrinolytic and esterolytic assays. Urokinase, but not plasmin, was inhibited by serum-free conditioned medium from cells incubated with 0.1 microM dexamethasone. The specificity of the inhibitor for plasminogen activator was demonstrated directly by the inhibition of the urokinase-catalyzed activation of 125I-plasminogen to 125I-plasmin. The inhibitory activity was stable to pH 3 for 2 h at 37 degrees C, a condition which inactivated fibrinolytic inhibitors in serum, suggesting a cellular origin for the inhibitor. Further evidence for the cellular origin was the constant daily production of inhibitor throughout a 4-day incubation with dexamethasone in serum-free medium. SF HTC-H1 cells, selected for their ability to grow in serum-free medium (Thompson, E. B., Anderson, C. U., and Lippman, M. E. (1975) J. Cell Physiol. 86, 403-412), were grown for 76 days (at least 30 generations) in the presence or absence of serum; dexamethasone induced equivalent amounts of inhibitory activity in cells which had been grown under both conditions. We conclude that the dexamethasone-induced inhibitor from HTC cells is a cellular product which is specific for the inhibition of plasminogen activation and which differs from other reported fibrinolytic inhibitors.
doi_str_mv 10.1016/S0021-9258(18)34715-X
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_74019133</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S002192581834715X</els_id><sourcerecordid>74019133</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-4bd263e1e6bc6d4e0465c1b838c4e0fc202d3fcc5d5ca124e003fb9747ecc2513</originalsourceid><addsrcrecordid>eNqFUctu1DAUtRCoDIVPqGSxQLBIsWPnMStUVbykSiwo0uws5-amuSiJg-20zIfwv3gmQ7d448c95_joHMYupLiUQpbvvwuRy2ybF_VbWb9TupJFtnvCNlLUKlOF3D1lm0fIc_YihJ8iLb2VZ-ys1KUsC71hf2575C3-tiPG3gY3YUZTuwC2nKaeGorOc9fxjhpPkxv2kYBbiHRPcZ8gvMfZRjdaDjgM4ZJfHQ_LYD2fvUtKkT_0BD0PMwJ1BHYY9v-0A58HG8YkfIfTKmsjuekle9bZIeCr037Ofnz6eHv9Jbv59vnr9dVNBlrpmOmmzUuFEssGylaj0GUBsqlVDenSQS7yVnUARVuAlXl6E6prtpWuECAvpDpnb1bdZPXXgiGakcLBv53QLcFUWsitVCoBixUI3oXgsTOzp9H6vZHCHOowxzrMIWsja3Osw-wS7-L0wdKM2D6yTvmn-et13tNd_0AeTUMOehxNXlSmNjovRQJ9WEGYorgn9CYA4ZQ6SgSIpnX0Hxt_AezKqlQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>74019133</pqid></control><display><type>article</type><title>The dexamethasone-induced inhibitor of fibrinolytic activity in hepatoma cells. A cellular product which specifically inhibits plasminogen activation</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Coleman, P L ; Barouski, P A ; Gelehrter, T D</creator><creatorcontrib>Coleman, P L ; Barouski, P A ; Gelehrter, T D</creatorcontrib><description>Dexamethasone induces an inhibitor of plasminogen-dependent fibrinolysis in rat hepatoma (HTC) cells. The specificity of the inhibitor for urokinase and plasmin was investigated using both fibrinolytic and esterolytic assays. Urokinase, but not plasmin, was inhibited by serum-free conditioned medium from cells incubated with 0.1 microM dexamethasone. The specificity of the inhibitor for plasminogen activator was demonstrated directly by the inhibition of the urokinase-catalyzed activation of 125I-plasminogen to 125I-plasmin. The inhibitory activity was stable to pH 3 for 2 h at 37 degrees C, a condition which inactivated fibrinolytic inhibitors in serum, suggesting a cellular origin for the inhibitor. Further evidence for the cellular origin was the constant daily production of inhibitor throughout a 4-day incubation with dexamethasone in serum-free medium. SF HTC-H1 cells, selected for their ability to grow in serum-free medium (Thompson, E. B., Anderson, C. U., and Lippman, M. E. (1975) J. Cell Physiol. 86, 403-412), were grown for 76 days (at least 30 generations) in the presence or absence of serum; dexamethasone induced equivalent amounts of inhibitory activity in cells which had been grown under both conditions. We conclude that the dexamethasone-induced inhibitor from HTC cells is a cellular product which is specific for the inhibition of plasminogen activation and which differs from other reported fibrinolytic inhibitors.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1016/S0021-9258(18)34715-X</identifier><identifier>PMID: 6461654</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Cell Line ; Culture Media ; Dexamethasone - pharmacology ; Fibrinolysin - antagonists &amp; inhibitors ; Fibrinolysis - drug effects ; Kinetics ; Liver Neoplasms, Experimental - physiopathology ; Plasminogen - metabolism ; Rats ; Urokinase-Type Plasminogen Activator - antagonists &amp; inhibitors</subject><ispartof>The Journal of biological chemistry, 1982-04, Vol.257 (8), p.4260-4264</ispartof><rights>1982 © 1982 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-4bd263e1e6bc6d4e0465c1b838c4e0fc202d3fcc5d5ca124e003fb9747ecc2513</citedby><cites>FETCH-LOGICAL-c434t-4bd263e1e6bc6d4e0465c1b838c4e0fc202d3fcc5d5ca124e003fb9747ecc2513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6461654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Coleman, P L</creatorcontrib><creatorcontrib>Barouski, P A</creatorcontrib><creatorcontrib>Gelehrter, T D</creatorcontrib><title>The dexamethasone-induced inhibitor of fibrinolytic activity in hepatoma cells. A cellular product which specifically inhibits plasminogen activation</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Dexamethasone induces an inhibitor of plasminogen-dependent fibrinolysis in rat hepatoma (HTC) cells. The specificity of the inhibitor for urokinase and plasmin was investigated using both fibrinolytic and esterolytic assays. Urokinase, but not plasmin, was inhibited by serum-free conditioned medium from cells incubated with 0.1 microM dexamethasone. The specificity of the inhibitor for plasminogen activator was demonstrated directly by the inhibition of the urokinase-catalyzed activation of 125I-plasminogen to 125I-plasmin. The inhibitory activity was stable to pH 3 for 2 h at 37 degrees C, a condition which inactivated fibrinolytic inhibitors in serum, suggesting a cellular origin for the inhibitor. Further evidence for the cellular origin was the constant daily production of inhibitor throughout a 4-day incubation with dexamethasone in serum-free medium. SF HTC-H1 cells, selected for their ability to grow in serum-free medium (Thompson, E. B., Anderson, C. U., and Lippman, M. E. (1975) J. Cell Physiol. 86, 403-412), were grown for 76 days (at least 30 generations) in the presence or absence of serum; dexamethasone induced equivalent amounts of inhibitory activity in cells which had been grown under both conditions. We conclude that the dexamethasone-induced inhibitor from HTC cells is a cellular product which is specific for the inhibition of plasminogen activation and which differs from other reported fibrinolytic inhibitors.</description><subject>Animals</subject><subject>Cell Line</subject><subject>Culture Media</subject><subject>Dexamethasone - pharmacology</subject><subject>Fibrinolysin - antagonists &amp; inhibitors</subject><subject>Fibrinolysis - drug effects</subject><subject>Kinetics</subject><subject>Liver Neoplasms, Experimental - physiopathology</subject><subject>Plasminogen - metabolism</subject><subject>Rats</subject><subject>Urokinase-Type Plasminogen Activator - antagonists &amp; inhibitors</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1982</creationdate><recordtype>article</recordtype><recordid>eNqFUctu1DAUtRCoDIVPqGSxQLBIsWPnMStUVbykSiwo0uws5-amuSiJg-20zIfwv3gmQ7d448c95_joHMYupLiUQpbvvwuRy2ybF_VbWb9TupJFtnvCNlLUKlOF3D1lm0fIc_YihJ8iLb2VZ-ys1KUsC71hf2575C3-tiPG3gY3YUZTuwC2nKaeGorOc9fxjhpPkxv2kYBbiHRPcZ8gvMfZRjdaDjgM4ZJfHQ_LYD2fvUtKkT_0BD0PMwJ1BHYY9v-0A58HG8YkfIfTKmsjuekle9bZIeCr037Ofnz6eHv9Jbv59vnr9dVNBlrpmOmmzUuFEssGylaj0GUBsqlVDenSQS7yVnUARVuAlXl6E6prtpWuECAvpDpnb1bdZPXXgiGakcLBv53QLcFUWsitVCoBixUI3oXgsTOzp9H6vZHCHOowxzrMIWsja3Osw-wS7-L0wdKM2D6yTvmn-et13tNd_0AeTUMOehxNXlSmNjovRQJ9WEGYorgn9CYA4ZQ6SgSIpnX0Hxt_AezKqlQ</recordid><startdate>19820425</startdate><enddate>19820425</enddate><creator>Coleman, P L</creator><creator>Barouski, P A</creator><creator>Gelehrter, T D</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19820425</creationdate><title>The dexamethasone-induced inhibitor of fibrinolytic activity in hepatoma cells. A cellular product which specifically inhibits plasminogen activation</title><author>Coleman, P L ; Barouski, P A ; Gelehrter, T D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-4bd263e1e6bc6d4e0465c1b838c4e0fc202d3fcc5d5ca124e003fb9747ecc2513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1982</creationdate><topic>Animals</topic><topic>Cell Line</topic><topic>Culture Media</topic><topic>Dexamethasone - pharmacology</topic><topic>Fibrinolysin - antagonists &amp; inhibitors</topic><topic>Fibrinolysis - drug effects</topic><topic>Kinetics</topic><topic>Liver Neoplasms, Experimental - physiopathology</topic><topic>Plasminogen - metabolism</topic><topic>Rats</topic><topic>Urokinase-Type Plasminogen Activator - antagonists &amp; inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Coleman, P L</creatorcontrib><creatorcontrib>Barouski, P A</creatorcontrib><creatorcontrib>Gelehrter, T D</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Coleman, P L</au><au>Barouski, P A</au><au>Gelehrter, T D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The dexamethasone-induced inhibitor of fibrinolytic activity in hepatoma cells. A cellular product which specifically inhibits plasminogen activation</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>1982-04-25</date><risdate>1982</risdate><volume>257</volume><issue>8</issue><spage>4260</spage><epage>4264</epage><pages>4260-4264</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>Dexamethasone induces an inhibitor of plasminogen-dependent fibrinolysis in rat hepatoma (HTC) cells. The specificity of the inhibitor for urokinase and plasmin was investigated using both fibrinolytic and esterolytic assays. Urokinase, but not plasmin, was inhibited by serum-free conditioned medium from cells incubated with 0.1 microM dexamethasone. The specificity of the inhibitor for plasminogen activator was demonstrated directly by the inhibition of the urokinase-catalyzed activation of 125I-plasminogen to 125I-plasmin. The inhibitory activity was stable to pH 3 for 2 h at 37 degrees C, a condition which inactivated fibrinolytic inhibitors in serum, suggesting a cellular origin for the inhibitor. Further evidence for the cellular origin was the constant daily production of inhibitor throughout a 4-day incubation with dexamethasone in serum-free medium. SF HTC-H1 cells, selected for their ability to grow in serum-free medium (Thompson, E. B., Anderson, C. U., and Lippman, M. E. (1975) J. Cell Physiol. 86, 403-412), were grown for 76 days (at least 30 generations) in the presence or absence of serum; dexamethasone induced equivalent amounts of inhibitory activity in cells which had been grown under both conditions. We conclude that the dexamethasone-induced inhibitor from HTC cells is a cellular product which is specific for the inhibition of plasminogen activation and which differs from other reported fibrinolytic inhibitors.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>6461654</pmid><doi>10.1016/S0021-9258(18)34715-X</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 1982-04, Vol.257 (8), p.4260-4264
issn 0021-9258
1083-351X
language eng
recordid cdi_proquest_miscellaneous_74019133
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Animals
Cell Line
Culture Media
Dexamethasone - pharmacology
Fibrinolysin - antagonists & inhibitors
Fibrinolysis - drug effects
Kinetics
Liver Neoplasms, Experimental - physiopathology
Plasminogen - metabolism
Rats
Urokinase-Type Plasminogen Activator - antagonists & inhibitors
title The dexamethasone-induced inhibitor of fibrinolytic activity in hepatoma cells. A cellular product which specifically inhibits plasminogen activation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T21%3A43%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20dexamethasone-induced%20inhibitor%20of%20fibrinolytic%20activity%20in%20hepatoma%20cells.%20A%20cellular%20product%20which%20specifically%20inhibits%20plasminogen%20activation&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Coleman,%20P%20L&rft.date=1982-04-25&rft.volume=257&rft.issue=8&rft.spage=4260&rft.epage=4264&rft.pages=4260-4264&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1016/S0021-9258(18)34715-X&rft_dat=%3Cproquest_cross%3E74019133%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c434t-4bd263e1e6bc6d4e0465c1b838c4e0fc202d3fcc5d5ca124e003fb9747ecc2513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=74019133&rft_id=info:pmid/6461654&rfr_iscdi=true